The present invention relates to new combinations of antitumour or anticancer agents for the tumour combination therapy, pharmaceutical compositions intended for combined use and kit containing compositions of different antitumour agents for combined use. In particular the present invention relates to combinations of various tumour agents with the PI3K-Class I inhibitor 5-(7-methanesulfonyl-2-morpholin-4-yl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-pyrimidin-2-il-amine or pharmaceutically acceptable salts thereof.本發明係關於用於腫瘤組合療法的抗腫瘤或抗癌症藥劑之新穎組合、意欲組合使用的醫藥組成物及含有供組合使用的不同抗腫瘤劑之組成物的套組。特別地，本發明係關於各種腫瘤藥劑與第I型PI3K抑制劑5-(7-甲磺醯基-2-啉-4-基-6,7-二氫-5H-吡咯并[2,3-d]嘧啶-4-基)-嘧啶-2-基-胺或其醫藥上可接受的鹽的組合。
